Increased TLR4 expression has been linked to several conditions, including hypoxia‐induced damage to intestinal barrier function and bacterial translocation [31], necrotizing enterocolitis [32], systemic inflammation induced by the chemotherapy drug doxorubicin [33], and neuroinflammation triggered by LPS [34]. This evidence concerns the gene TLR4 and necrotizing enterocolitis.